People

Dr Carlos Wong

Associate Professor

Profile for Carlos Wong

School/Department: Diabetes Research Centre

Email: [email protected]

Profile

Dr Carlos Wong joined the Leicester Diabetes Centre and NIHR Leicester Biomedical Research Centre in May 2026. Prior to joining Leicester, he was an Associate Professor and Intercalating Academic Co-Lead at the London School of Hygiene & Tropical Medicine, Senior Research Director at the Laboratory of Data Discovery for Health, and an Assistant Professor at the University of Hong Kong.

Carlos is an Honorary Associate Professor at the School of Public Health, The University of Hong Kong, and an Honorary Consultant at the Initiative for Technology Evaluation and Cost-effectiveness in Healthcare, The Chinese University of Hong Kong, and the Faculty of Health and Social Sciences Clinical Trials Unit, The Hong Kong Polytechnic University. He is a member of the EuroQol Group and the Vaccine Confidence Project™ team.

Carlos received his BSc in Mathematics (First Class Honour) and MPhil in Mathematics in the Hong Kong University of Science and University, and PhD in the University of Hong Kong. 

Carlos has over a decade of experience in health economic analysis and the analysis of routinely collected data using electronic health records, and more recently focused on the development and application of AI tools in healthcare. His research has been supported by the EuroQol Research Foundation, the Hong Kong government Innovation and Technology Commission, Food and Health Bureau, Research Grants Council, and industry partners, securing over £1 million in research funding as a principal investigator or co-principal investigator. He and his team reported the world’s first real-world evidence on the effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among patients with SARS-CoV-2 infection during the Omicron wave. He has been ranked in the Stanford's Top 2% Scientists worldwide for multiple years. 

He has served as an Associate Editor for the IEEE Journal of Biomedical and Health Informatics since 2026, a Statistical Advisor for the Hong Kong Medical Journal since 2017, a Editorial Board Member for the Primary Care Diabetes since 2021, an external reviewer of funding applications in the UK and Singapore, and an academic reviewer of journals including The Lancet, The Lancet Infectious Diseases, The Lancet Respiratory Medicine, BMJ, Diabetes Care and Nature Communications.

Publications

For a complete and up-to-date list of publications, see my Scopus and Google Scholar profile.

Highlighted publications

Generating real-world evidence using electronic health records

  • Carlos KH Wong, Kristy TK Lau, Matthew SH Chung, Ivan CH Au, Ka Wang Cheung, Eric HY Lau, Yasmin Daoud, Benjamin J. Cowling, Gabriel M. Leung. Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation. Nature Medicine 2024;30:112-116. DOI: 10.1038/s41591-023-02674-0
  • Carlos KH Wong, Kristy TK Lau, Ivan CH Au, Eric HY Lau, Leo LM Poon, Ivan FN Hung, Benjamin J Cowling, Gabriel M Leung. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. The Lancet Infectious Diseases 2023;23(6):683-695. DOI: 10.1016/ S1473-3099(22)00873-8
  • Carlos KH Wong, Kristy TK Lau, Gabriel M Leung. Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants. The Lancet Infectious Diseases 2023;23(6):639-640, DOI: 10.1016/S1473-3099(23)00056-7 (Commentary)
  • Carlos KH Wong, Ivan CH Au, Kristy TK Lau, Eric HY Lau, Benjamin J Cowling, Gabriel M Leung. Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study. Lancet 2022;400(10359):1213-1222. DOI: 10.1016/S0140-6736(22)01586-0
  • Carlos KH Wong, Ivan CH Au, Kristy TK Lau, Eric HY Lau, Benjamin J Cowling, Gabriel M Leung, Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study. The Lancet Infectious Diseases 2022;22(12):1681-1693. DOI: 10.1016/S1473-3099(22)00507-2
  • Carlos KH Wong, Lung Yi Mak, Ivan CH Au, Francisco TT Lai, Xue Li, Eric YF Wan, Celine SL Chui, Esther WY Chan, Wing Yiu Cheng, Franco WT Cheng, Man Fung Yuen, Ian CK Wong, Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. Journal of Hepatology 2022;77(5):1339-1348, DOI: 10.1016/j.jhep.2022.06.032

Development and application of AI

  • Matrix MH Fung, Eric HM Tang, Tingting Wu, Yan Luk, Ivan CH Au, Xiaodong Liu, Victor HF Lee, Chun Ka Wong, Zhili Wei, Wing Yiu Cheng, Isaac CY Tai, Joshua WK Ho, Jason WH Wong, Brian HH Lang, Kathy SM Leung, Zoie SY Wong, Joseph T Wu, Carlos KH Wong. Developing a named entity framework for thyroid cancer staging and risk level classification using large language models. npj Digital Medicine 2025;8:134. DOI: 10.1038/s41746-025-01528-y

Supervision

I have supervised and co-supervised nine PhD candidates, serving as primary supervisor for five doctoral students and co-supervisor/advisory committee member for four others.

LKS Faculty of Medicine, The University of Hong Kong

Primary Supervisor and Co-supervisor

  • Matthew Chung — Full-time PhD. Primary supervisor: September 2022 – July 2023. Co-supervisor: August 2023 – July 2026. Thesis title: Hepatocellular carcinoma treatment and disease burden in chronic liver disease: Real-world evidence in Hong Kong in the peri-pandemic era. Awards and achievements: HKUMed Doctoral Entrance Scholarship for Medical Research Excellence; Faculty Outstanding Research Output Award (2024); Best Oral Presentation Award, APASL - AASLD Workshop, The Asian Pacific Association for the Study of the Liver, Beijing, China (2025); Poster of Distinction for The Liver Meeting 2025, The American Association for the Study of Liver Diseases, Washington D.C,, US (2025)
  • Ivan Au — Full-time PhD. Primary supervisor: 1 September 2021 – 31 July 2023. Co-supervisor: August 2023 – November 2025. Thesis title: Effectiveness of Nirmatrelvir/ritonavir in Patients with SARS-CoV-2 Omicron Infection in Hong Kong: Target Trial Emulations. Awards and achievements: Faculty Outstanding Research Output Award (2023, 2024); Research attachment, Public Health, University of Glasgow (November 2024 – February 2025)
  • Xi Xiong — Full-time PhD. Primary supervisor: 1 September 2020 – 31 July 2023. Co-supervisor: 1 August 2023 – 31 August 2024. Thesis title: Real-World Evidence of the Incidence of Endocrine-Related Disorder Following COVID-19 Vaccination and SARS-CoV-2 Infection. Awards and achievements: 2024 John Snow Award, International Society for Pharmacoepidemiology; Research attachment, Public Health, University of Glasgow (September 2023 – January 2024)
  • Eric Tang — Part-time PhD. Primary supervisor: 1 September 2019 – 31 August 2023. Thesis title: Evaluation of Long-term Effectiveness and Cost-effectiveness of the Risk Assessment and Management Programme–Diabetes Mellitus of the Hospital Authority in Hong Kong. Awards and achievements: Hong Kong College of Family Physicians Best Research Award (2022); Winning Poster, 8th Asia Pacific Primary Care Research Conference, Malaysia (July 2021)
  • Tingting Wu — Full-time PhD. Primary supervisor: 1 September 2018 – August 2022. Thesis title: Clinical Effectiveness and Cost-Effectiveness of Bariatric Surgery among Patients with Type 2 Diabetes Mellitus and Obesity. Awards and achievements: Research attachment, Health Economics and Health Technology Assessment (HEHTA), University of Glasgow (October–November 2021); Young Investigator Award (ePoster Presentation), 15th International Symposium on Healthy Aging, Hong Kong (March 2021); Best Paper Award, 11th Hua Xia Pharmacoeconomics and Health Technology Assessment Forum, Nanjing, China (2019)

Co-supervisor

  • Xiaodong Liu — Full-time PhD. Supervision period: 1 September 2019 – 31 August 2023. Thesis title: Effectiveness and Cost-Effectiveness of Thyroidectomy in the Management of Graves’ Disease in Hong Kong. Awards and achievements: Outstanding Research Postgraduate Award, Department of Surgery (2023); Outstanding Research Postgraduate Award, Department of Surgery (2021); YS and Christabel Lung Postgraduate Scholarship (2022/23)
  • Lanlan Li — Full-time PhD. Supervision period: 1 June 2023 – present. Research attachment: Public Health, University of Glasgow (August 2025 – February 2026)
  • Sau Nga Fu — Part-time PhD. Supervision period: 1 July 2015 – 30 June 2021. Thesis title: Using Self-Blood Pressure Monitoring to Improve Hypertension Control in Patients with Lower Health Literacy
  • Dovey Weinan Dong — Full-time PhD. Supervision period: 1 June 2018 – 31 July 2022. Thesis title: Application of Medicine Learning in the Development of Risk Prediction Models of Cardiovascular and Renal Complications in Primary Care Chinese Diabetes Mellitus Patients

Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine

Suladda Pongutta — Advisory Committee Member, part-time PhD (2021–2024). Thesis title: The Impact of Complex School Nutrition Programmes on the Nutritional Status of School-Aged Children: A Review of Asian Countries’ Experiences and Lessons from a Case Study in Thailand

Awards

World’s Top 2% Scientists, Stanford University, 2023–2026.

Faculty Outstanding Research Output Award, LKS Faculty of Medicine, University of Hong Kong, 2019, 2022-2024. Recognised for research on the real-world effectiveness of oral antivirals for COVID-19 and COVID-19 vaccine safety. 

Faculty Knowledge Exchange Award, LKS Faculty of Medicine, University of Hong Kong, 2023, for Big-data pharmacovigilance of COVID-19 vaccines shapes public health policies.

10th HMRF Anniversary Award, Health Research Symposium, Food & Health Bureau, Hong Kong SAR, 2021, for research on health-related quality of life and the cost-effectiveness of colorectal cancer screening.

Excellent Research Award, Health Research Symposium, Food & Health Bureau, Hong Kong SAR, 2017, for research on health-related quality of life and the cost-effectiveness of colorectal cancer screening.

Poster Award Finalist, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Glasgow, 2017.

Best Poster Award, Health Research Symposium, Food & Health Bureau, Hong Kong SAR, 2014, for research on health-related quality of life and the cost-effectiveness of colorectal cancer screening.

Best Student Poster Presentation Award, 19th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Budapest, 2012.

Shortlisted for Best Student Oral Presentation Award, 18th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Denver, 2011.

Best Student Oral Presentation Award, 17th Annual Conference of the International Society for Quality of Life Research (ISOQOL), London, 2010.

Qualifications

BSc in Mathematics, Hong Kong University of Science and University

MPhil in Mathematics, Hong Kong University of Science and University

PhD - Department of Family Medicine and Primary Care, The University of Hong Kong. 

Back to top
MENU